Dose Finding Study of [177Lu]Lu-NeoB in Combination With RT and TMZ in Newly Diagnosed GBM.
Status:
Not yet recruiting
Trial end date:
2025-01-17
Target enrollment:
Participant gender:
Summary
This study will investigate different doses of [177Lu]Lu-NeoB in combination with RT and TMZ
in participants with newly diagnosed GBM with methylated or unmethylated promoter to assess
the safety and efficacy of [177Lu]Lu-NeoB in combination with the SoC to identify the
recommended dose and to also explore the safety of the PET imaging agent [68Ga]Ga-NeoB and
characterize its uptake in the tumor area.